0001493152-26-019340.txt : 20260428 0001493152-26-019340.hdr.sgml : 20260428 20260428161530 ACCESSION NUMBER: 0001493152-26-019340 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260428 DATE AS OF CHANGE: 20260428 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-33655 FILM NUMBER: 26908012 BUSINESS ADDRESS: STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR CITY: CLEVELAND STATE: OH ZIP: 44103 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR CITY: CLEVELAND STATE: OH ZIP: 44103 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HIRSCHMAN ORIN CENTRAL INDEX KEY: 0001131362 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SCHEDULE 13G MAIL ADDRESS: STREET 1: 101 EAST 52ND ST CITY: NEW YORK STATE: NY ZIP: 10022 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001131362 XXXXXXXX LIVE Common Stock, $0.01 par value 03/31/2026 0000318306 ABEONA THERAPEUTICS INC. 00289Y206 6555 Carnegie Avenue 4th Floor Cleveland OH 44103 Rule 13d-1(b) Orin Hirschman b X1 3100000.00 0.00 3100000.00 0.00 3100000.00 N 5.4 HC IN AIGH Capital Management LLC b DE 3100000.00 0.00 3100000.00 0.00 3100000.00 N 5.4 IA OO ABEONA THERAPEUTICS INC. 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, 44103 This Schedule 13G is being jointly filed by each of the following persons pursuant to Rule 13d-1 promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the "Act"): (i) AIGH Capital Management, LLC, a Maryland limited liability company ("AIGH CM"), as an Advisor or Sub-Advisor with respect to shares of Common Stock (as defined in Item 2(d) below) held by AIGH Investment Partners, L.P., and WVP Emerging Manger Onshore Fund, LLC - AIGH Series. (ii) AIGH Investment Partners, L.L.C., a Delaware limited liability company ("AIGH LLC";), with respect to shares of Common Stock (as defined in Item 2(d) below) directly held by it; (iii) Mr. Orin Hirschman ("Mr. Hirschman"), who is the Managing Member of AIGH Capital Management, LLC and president of AIGH LLC, with respect to shares of Common Stock (as defined in Item 2(d) below) indirectly held through AIGH CM, directly by AIGH LLC and Mr. Hirschman and his family directly. AIGH Capital Management LLC., AIGH Investment Partners LLC, and Mr. Hirschman are hereinafter sometimes collectively referred to as the "Reporting Persons." Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The principal office and business address of AIGH Capital Management LLC, AIGH Investment Partners LLC, and Mr.Hirschman is: 6006 Berkeley Avenue, Baltimore MD 21209 See Item 2(a) above and Item 4 of each cover page. N IA 3,100,000 5.4 3,100,000 0 3,100,000 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Orin Hirschman /s/ Orin Hirschman Orin Hirschman 04/28/2026 AIGH Capital Management LLC /s/ Orin Hirschman Orin Hirschman, Managing Member 04/28/2026